Skip to Content Facebook Feature Image

China ready to push ties with Argentina to higher level: FM

China

China

China

China ready to push ties with Argentina to higher level: FM

2025-02-15 22:02 Last Updated At:02-16 15:47

China is ready to work with Argentina to implement the important consensus reached by the leaders of the two countries and bring the bilateral relations to a new level, Chinese Foreign Minister Wang Yi said on Friday.

This will benefit the people of the two countries and help China and Latin America achieve common development and prosperity, Wang said. He made the remarks during a meeting with his Argentine counterpart Gerardo Werthein on the sidelines of the ongoing Munich Security Conference.

Wang, also a member of the Political Bureau of the Communist Party of China Central Committee, said that the Chinese and Argentine people have enjoyed a long-standing friendship, and China-Argentina cooperation is equal and mutually beneficial.

Last year, Chinese President Xi Jinping and Argentine President Javier Milei held a meeting and reached important consensus on consolidating and developing bilateral relations, said Wang.

China is willing to work with Argentina to implement the consensus reached by the two heads of state and strengthen exchanges at the high level and in all fields, so as to bring the bilateral relations to a new level and better benefit the people of both countries, he said.

Wang also said the two sides should continue to respect and accommodate each other's core interests and major concerns, and continuously consolidate the political foundation of bilateral relations.

Wang pointed out that China does not seek spheres of influence, nor does it participate in geopolitical competition. In international affairs, China firmly practices multilateralism and is willing to work with Latin American countries, including Argentina, to firmly safeguard the international rule of law and the basic norms of international relations, he said.

Wang noted that China-Argentina relations are an important part of China-Latin America relations. Over the past decade since its establishment, the China-Community of Latin American and Caribbean States (CELAC) Forum has effectively promoted China-Latin America cooperation and brought tangible benefits to the people of both sides, he said.

China is willing to work with Latin American countries to support the development and growth of the China-CELAC Forum, helping China and Latin America achieve common development and prosperity, said Wang.

Werthein said that Argentina attaches great importance to its relations with China, and looks forward to strengthening high-level exchanges and deepening pragmatic cooperation with China.

Noting that Argentina appreciates China's support for Argentina's defense of its sovereignty over the Malvinas Islands, Werthein said Argentina firmly adheres to the one-China principle and is willing to become a reliable and stable cooperative partner of China.

Werthein also said that Argentina will play an active role in promoting the development of Latin America-China relations on the basis of strengthening bilateral relations.

China ready to push ties with Argentina to higher level: FM

China ready to push ties with Argentina to higher level: FM

China ready to push ties with Argentina to higher level: FM

China ready to push ties with Argentina to higher level: FM

Next Article

China's new drug registration applications hit record high in 2024

2025-03-19 03:44 Last Updated At:04:57

China's National Medical Products Administration (NMPA) reviewed a record number of new drug registration applications in 2024, marking a year-on-year increase of 16.2 percent, with antineoplastic drugs accounting for the largest share, according to the administration.

In 2024, the NMPA evaluated a total of 18,259 drug registration applications, a figure that reflects the vitality of China's innovation in drug research and development.

"The record number of reviewed drug applications is a clear sign of China's rapidly growing biopharmaceutical industry. The approval of high-quality new drugs not only gives Chinese patients more and better treatment options, but also shows China's increasing role in the global pharmaceutical market, offering more Chinese solutions to patients around the world," said Yuan Lijia, a staff member at the Center for Drug Evaluation under the NMPA.

Notably, in 2024, applications for clinical trial and market approval of new anti-tumor drugs ranked first among all chemical drugs and biologics, accounting for even half of the total.

"In 2024, anti-tumor drugs made up the largest share of approved clinical trial applications, with over 41 percent being chemical drugs and more than 55 percent being biologics. Throughout the year, anti-tumor drugs also led in the number of innovative drugs approved, with both chemical drugs and biologics surpassing 36 percent," said Geng Ying, an official with the center.

In 2024, China approved the market entry of 48 innovative drugs and 65 innovative medical devices. Its number of drugs in development ranked second globally, and several domestically developed drugs gained approval for global markets.

China's new drug registration applications hit record high in 2024

China's new drug registration applications hit record high in 2024

Recommended Articles